Inc., a company specializing in electromedical and electrotherapeutic apparatus with a market capitalization of $44 million, announced on Thursday a significant amendment to its corporate bylaws ...
BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease from the previous $4.00, while continuing to recommend a Buy rating for the ...
BTIG lowered the firm’s price target on Outset Medical (OM) to $3 from $4 and keeps a Buy rating on the shares. The firm is updating its model ...
NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Outset Medical, Inc. (NASDAQ: OM ...
To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Outset Medical expects to receive $168.8 million in financing through a private placement of convertible ...
Outset Medical, Inc. has successfully closed a private placement, issuing 863,340 shares of Series A Non-Voting Convertible Preferred Stock and entered into a $100 million credit agreement with ...
Outset Medical has announced a $169 million private placement financing and a new debt facility of up to $125 million, aiming to retire prior debt and bolster its financial position. This ...
Outset Medical, Inc. (OM) stock price is 0.85 and Outset Medical, Inc. (OM) 10-day simple moving average is 0.81. Outset Medical, Inc. (OM) stock price is 0.85 and Outset Medical, Inc. (OM ...
SAN JOSE, CA – Outset Medical (TASE:PMCN), Inc. (NASDAQ:OM), a medical technology company with a market capitalization of $52 million, announced the closure of a private placement offering and ...
Outset Medical, Inc. SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to ...
SAN JOSE, CA – Outset Medical (TASE:PMCN), Inc., a company specializing in electromedical and electrotherapeutic apparatus with a market capitalization of $44 million, announced on Thursday a ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...